Prelude Therapeutics PRLD
NASDAQ PRLD
$3.76 +0.16 (+4.44%)
At close: Nov 9, 2026 · 4:00 PM EST

Prelude Therapeutics (PRLD) Preferred Stock Liabilities (2019 - 2020)

Updated

Prelude Therapeutics (PRLD) posted Preferred Stock Liabilities of $96.39 million for Q2 2020, unchanged from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Prelude Therapeutics' Preferred Stock Liabilities came in at $66.44 million.

  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $96.39 million (Q1 2020), $66.44 million (Q4 2019) and $66.44 million (Q3 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Prelude Therapeutics 366.99 Mn -230.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 96.39 Mn
Mar 31, 2020 96.39 Mn
Dec 31, 2019 66.44 Mn
Sep 30, 2019 66.44 Mn
API Access

Prelude Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PRLD&period=max&api_key=YOUR_API_KEY